• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟酰胺磷酸核糖基转移酶作为感染性胸腔积液诊断的生物标志物。

Nicotinamide phosphoribosyltransferase as a biomarker for the diagnosis of infectious pleural effusions.

机构信息

Department of Pharmacy, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, 315020, China.

Department of Pulmonary and Critical Care Medicine, The Affiliated Hospital of Medical School of Ningbo University, Ningbo, 315020, China.

出版信息

Sci Rep. 2021 Oct 26;11(1):21121. doi: 10.1038/s41598-021-00653-4.

DOI:10.1038/s41598-021-00653-4
PMID:34702907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8548599/
Abstract

Nicotinamide phosphoribosyltransferase (NAMPT) has been reported to be involved in infectious diseases, but it is unknown whether it plays a role in infectious pleural effusions (IPEs). We observed the levels of NAMPT in pleural effusions of different etiologies and investigated the clinical value of NAMPT in the differential diagnosis of infectious pleural effusions. A total of 111 patients with pleural effusion were enrolled in the study, including 25 parapneumonic effusions (PPEs) (17 uncomplicated PPEs, 3 complicated PPEs, and 5 empyemas), 30 tuberculous pleural effusions (TPEs), 36 malignant pleural effusions (MPEs), and 20 transudative effusions. Pleural fluid NAMPT levels were highest in the patients with empyemas [575.4 (457.7, 649.3) ng/ml], followed by those with complicated PPEs [113.5 (103.5, 155.29) ng/ml], uncomplicated PPEs [24.9 (20.2, 46.7) ng/ml] and TPEs [88 (19.4, 182.6) ng/ml], and lower in patients with MPEs [11.5 (6.5, 18.4) ng/ml] and transudative effusions [4.3 (2.6, 5.1) ng/ml]. Pleural fluid NAMPT levels were significantly higher in PPEs (P < 0.001) or TPEs (P < 0.001) than in MPEs. Moreover, Pleural fluid NAMPT levels were positively correlated with the neutrophil percentage and lactate dehydrogenase (LDH) levels and inversely correlated with glucose levels in both PPEs and TPEs, indicating that NAMPT was implicated in the neutrophil-associated inflammatory response in infectious pleural effusion. Further, multivariate logistic regression analysis showed pleural fluid NAMPT was a significant predictor distinguishing PPEs from MPEs [odds ratio (OR) 1.180, 95% confidence interval (CI) 1.052-1.324, P = 0.005]. Receiver-operating characteristic (ROC) analysis demonstrated that NAMPT was a promising diagnostic factor for the diagnosis of infectious effusions, with the areas under the curve for pleural fluid NAMPT distinguishing PPEs from MPEs, TPEs from MPEs, and IPEs (PPEs and TPEs) from NIPEs were 0.92, 0.85, and 0.88, respectively. In conclusion, pleural fluid NAMPT could be used as a biomarker for the diagnosis of infectious pleural effusions.

摘要

烟酰胺磷酸核糖基转移酶(NAMPT)已被报道参与感染性疾病,但尚不清楚其是否在感染性胸腔积液(IPEs)中发挥作用。我们观察了不同病因胸腔积液中的 NAMPT 水平,并研究了 NAMPT 在感染性胸腔积液鉴别诊断中的临床价值。共纳入 111 例胸腔积液患者,包括 25 例类肺炎性胸腔积液(PPEs)(17 例单纯性 PPEs、3 例复杂性 PPEs 和 5 例脓胸)、30 例结核性胸腔积液(TPEs)、36 例恶性胸腔积液(MPEs)和 20 例漏出性胸腔积液。脓胸患者胸腔液 NAMPT 水平最高[575.4(457.7,649.3)ng/ml],其次是复杂性 PPEs[113.5(103.5,155.29)ng/ml]、单纯性 PPEs[24.9(20.2,46.7)ng/ml]和 TPEs[88(19.4,182.6)ng/ml],MPEs 患者的水平较低[11.5(6.5,18.4)ng/ml],漏出性胸腔积液患者的水平最低[4.3(2.6,5.1)ng/ml]。PPEs(P<0.001)或 TPEs(P<0.001)中 NAMPT 水平显著高于 MPEs。此外,PPEs 和 TPEs 中 NAMPT 水平与中性粒细胞百分比和乳酸脱氢酶(LDH)水平呈正相关,与葡萄糖水平呈负相关,提示 NAMPT 参与感染性胸腔积液中与中性粒细胞相关的炎症反应。进一步的多变量逻辑回归分析显示,胸腔液 NAMPT 是区分 PPEs 和 MPEs 的显著预测因子[比值比(OR)1.180,95%置信区间(CI)1.052-1.324,P=0.005]。受试者工作特征(ROC)分析表明,NAMPT 是诊断感染性渗出液的有前途的诊断因素,其曲线下面积(AUC)分别为区分 PPEs 与 MPEs、TPEs 与 MPEs 以及 IPEs(PPEs 和 TPEs)与 NIPEs 的 0.92、0.85 和 0.88。总之,胸腔液 NAMPT 可作为诊断感染性胸腔积液的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42e/8548599/37ba0a15125a/41598_2021_653_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42e/8548599/6458f18bab3e/41598_2021_653_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42e/8548599/0aa1b9a75310/41598_2021_653_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42e/8548599/4776c27614ef/41598_2021_653_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42e/8548599/bb97229ae031/41598_2021_653_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42e/8548599/37ba0a15125a/41598_2021_653_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42e/8548599/6458f18bab3e/41598_2021_653_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42e/8548599/0aa1b9a75310/41598_2021_653_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42e/8548599/4776c27614ef/41598_2021_653_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42e/8548599/bb97229ae031/41598_2021_653_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d42e/8548599/37ba0a15125a/41598_2021_653_Fig5_HTML.jpg

相似文献

1
Nicotinamide phosphoribosyltransferase as a biomarker for the diagnosis of infectious pleural effusions.烟酰胺磷酸核糖基转移酶作为感染性胸腔积液诊断的生物标志物。
Sci Rep. 2021 Oct 26;11(1):21121. doi: 10.1038/s41598-021-00653-4.
2
Association between elevated pleural interleukin-33 levels and tuberculous pleurisy.胸腔白细胞介素-33 水平升高与结核性胸膜炎的关系。
Ann Lab Med. 2013 Jan;33(1):45-51. doi: 10.3343/alm.2013.33.1.45. Epub 2012 Dec 17.
3
Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels.腺苷脱氨酶水平高的结核性与恶性胸腔积液的实验室及影像学鉴别
Korean J Intern Med. 2022 Jan;37(1):137-145. doi: 10.3904/kjim.2020.246. Epub 2021 Jul 15.
4
Combined detections of interleukin 27, interferon-γ, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy.胸腔积液中白细胞介素 27、干扰素-γ 和腺苷脱氨酶联合检测对结核性胸膜炎的诊断价值。
Chin Med J (Engl). 2013;126(17):3215-21.
5
Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.降钙素原作为鉴别脓胸性胸腔积液与结核性胸膜炎或恶性胸腔积液的诊断标志物。
Clin Biochem. 2013 Oct;46(15):1484-8. doi: 10.1016/j.clinbiochem.2013.03.018. Epub 2013 Apr 6.
6
Cancer ratio and other new parameters for differentiation between malignant and nonmalignant pleural effusions.癌症比例和其他用于区分恶性和非恶性胸腔积液的新参数。
Pol Arch Intern Med. 2018 Jun 30;128(6):354-361. doi: 10.20452/pamw.4278. Epub 2018 Jun 5.
7
Pleural fluid lactate as a point-of-care adjunct diagnostic aid to distinguish tuberculous and complicated parapneumonic pleural effusions during initial thoracentesis: Potential use in a tuberculosis endemic setting.在首次胸腔穿刺时,将胸腔积液乳酸作为即时辅助诊断手段,以区分结核性和复杂性类肺炎性胸腔积液:在结核病流行地区的潜在应用。
Respir Investig. 2020 Sep;58(5):367-375. doi: 10.1016/j.resinv.2020.01.004. Epub 2020 Feb 24.
8
Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.通过蛋白质组学方法鉴定区分结核性和恶性胸腔积液的10种候选生物标志物
Yonsei Med J. 2017 Nov;58(6):1144-1151. doi: 10.3349/ymj.2017.58.6.1144.
9
Pleural fluid procalcitonin to distinguish infectious from noninfectious etiologies of pleural effusions.用胸腔积液降钙素原区分胸腔积液的感染性与非感染性病因。
J Hosp Med. 2016 May;11(5):363-5. doi: 10.1002/jhm.2551. Epub 2016 Jan 28.
10
Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.特发性胸腔积液:特征与细胞学阴性恶性胸腔积液的鉴别。
Am J Med Sci. 2020 Sep;360(3):236-242. doi: 10.1016/j.amjms.2020.04.020. Epub 2020 Apr 25.

引用本文的文献

1
Tired of the confusion around pleural effusions: Adenosine deaminase detection sets the record straight!厌倦了围绕胸腔积液的种种困惑:腺苷脱氨酶检测澄清事实!
World J Clin Cases. 2025 Jul 26;13(21):106945. doi: 10.12998/wjcc.v13.i21.106945.
2
Infective Pleural Effusions-A Comprehensive Narrative Review Article.感染性胸腔积液——一篇综合性叙述性综述文章
Clin Pract. 2024 May 16;14(3):870-881. doi: 10.3390/clinpract14030068.
3
Pleural Space Infections.胸腔感染

本文引用的文献

1
Serum level of visfatin can reflect the severity of inflammation in patients with acute cholecystitis.内脂素血清水平可反映急性胆囊炎患者的炎症严重程度。
Ann Surg Treat Res. 2020 Jul;99(1):26-36. doi: 10.4174/astr.2020.99.1.26. Epub 2020 Jun 29.
2
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation.烟酰胺磷酸核糖转移酶(NAMPT)和烟酰胺磷酸核糖基转移酶(NAPRT):在炎症中起关键作用的两种代谢酶。
Front Oncol. 2020 Mar 19;10:358. doi: 10.3389/fonc.2020.00358. eCollection 2020.
3
Visfatin as a therapeutic target for rheumatoid arthritis.
Life (Basel). 2023 Jan 29;13(2):376. doi: 10.3390/life13020376.
4
Malignant Pleural Effusions: Updates in Diagnosis and Management.恶性胸腔积液:诊断与治疗的新进展
Life (Basel). 2022 Dec 31;13(1):115. doi: 10.3390/life13010115.
内脏脂肪素作为类风湿关节炎的治疗靶点。
Expert Opin Ther Targets. 2019 Jul;23(7):607-618. doi: 10.1080/14728222.2019.1617274. Epub 2019 May 15.
4
Essential Role of Visfatin in Lipopolysaccharide and Colon Ascendens Stent Peritonitis-Induced Acute Lung Injury.脂联素在脂多糖和结肠升支支架腹膜炎诱导的急性肺损伤中的重要作用。
Int J Mol Sci. 2019 Apr 4;20(7):1678. doi: 10.3390/ijms20071678.
5
Diagnosis of Parapneumonia Pleural Effusion with Serum and Pleural Fluid Cell-Free DNA.血清和胸腔积液无细胞 DNA 对类肺炎性胸腔积液的诊断。
Biomed Res Int. 2019 Mar 4;2019:5028512. doi: 10.1155/2019/5028512. eCollection 2019.
6
Circulating eNampt and resistin as a proinflammatory duet predicting independently mortality in critically ill patients with sepsis: A prospective observational study.
Cytokine. 2019 Jul;119:62-70. doi: 10.1016/j.cyto.2019.03.002. Epub 2019 Mar 15.
7
Diagnostic performance of C-reactive protein for parapneumonic pleural effusion: a meta-analysis.C反应蛋白对肺炎旁胸腔积液的诊断效能:一项荟萃分析
Ann Transl Med. 2019 Jan;7(1):1. doi: 10.21037/atm.2018.11.44.
8
The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions.胸腔积液降钙素原前肽、C 反应蛋白在鉴别胸腔积液病因中的作用。
BMC Pulm Med. 2018 Nov 23;18(1):176. doi: 10.1186/s12890-018-0740-3.
9
Biomarkers in the diagnosis of pleural diseases: a 2018 update.胸腔疾病诊断中的生物标志物:2018 年更新。
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618808660. doi: 10.1177/1753466618808660.
10
Infectious pleural effusion status and treatment progress.感染性胸腔积液的现状与治疗进展
J Thorac Dis. 2017 Nov;9(11):4690-4699. doi: 10.21037/jtd.2017.10.96.